Document:

Form of Performance Share Grant Agreement

 Exhibit 10.2 
 PERFORMANCE AWARD AGREEMENT 
 This Performance Award Agreement (the
“Agreement”) has been made as of                      (the “Date of Grant”) between Duke Energy Corporation, a
Delaware corporation, with its principal offices in Charlotte, North Carolina (the “Corporation”), and                      (the
“Grantee”). 
 RECITALS 
 Under the [                            ] as it may, from time to time, be amended (the
“Plan”), the Compensation Committee of the Board of Directors of the Corporation (the “Committee”), or its delegatee, has determined the form of this Agreement and selected the Grantee, as an Employee, to receive the award
evidenced by this Agreement (the “Award”) and the Performance Shares and tandem Dividend Equivalents that are subject hereto. The applicable provisions of the Plan are incorporated in this Agreement by reference, including the definitions
of terms contained in the Plan (unless such terms are otherwise defined herein). 
 AWARD 
 In accordance with the Plan, the Corporation has made this Award, effective as of the Date of Grant and upon the following terms and conditions:

 Section 1. Number and Nature of Performance Shares and Tandem Dividend Equivalents. The number of
Performance Shares and the number of tandem Dividend Equivalents subject to this Award are each                     
(            ). The number of such Performance Shares that may become vested upon determination of achievement of the Performance Goal at Target, as provided in
Section 2(a), is                      (    ). Each Performance Share, upon becoming vested before its
expiration, represents a right to receive payment in the form of one (1) share of Common Stock. Each tandem Dividend Equivalent, after its tandem Performance Share vests, represents a right to receive a cash payment equivalent in amount to the
aggregate cash dividends declared and paid on one (1) share of Common Stock for the period beginning on the Date of the Award and ending on the date the vested, tandem Performance Share is paid or deferred. Performance Shares and Dividend
Equivalents are used solely as units of measurement, and are not shares of Common Stock and the Grantee is not, and has no rights as, a shareholder of the Corporation by virtue of this Award. 
 Section 2. Vesting of Performance Shares. (a) Provided Grantee’s continuous employment by the Corporation, including
Subsidiaries, has not terminated, or as otherwise provided in Sections 2(b) or 2(c), Performance Shares subject to this Award 

 shall become vested upon the written determination by the Committee, or its delegatee, in its sole discretion, of the
achievement of the Performance Goal, which is the Corporation’s Total Shareholder Return (“TSR”) percentile ranking among Standard & Poor’s 500 companies, with higher percentile ranking from more positive/less negative
TSR, for the period beginning                      and ending
                     (“Performance Period”), at, or above, the     th percentile, in accordance with the applicable vesting percentage specified for such percentile ranking in the following schedule: 
  

			
	 Percentile Ranking
	  	 Vesting Percentage

  
  

	 	*	When such determination is of a percentile ranking between those specified, the Committee, or its delegatee, in its sole discretion, shall interpolate to determine the applicable
vesting percentage. 

 and such Performance Shares that do not so become vested shall be forfeited. Notwithstanding the foregoing, should the
Committee, or its delegatee, in its sole discretion, determine that the Corporation’s TSR percentile ranking among Standard & Poor’s 500 Utilities Index companies, with higher percentile ranking for more positive/less negative
TSR, for the Performance Period, was lower than the     th percentile, then the
Committee, or its delegatee, in its sole discretion, may reduce, or eliminate in its entirety, any vesting of Performance Shares subject to this Award that would have otherwise occurred. For purposes of this Agreement, TSR means the change in fair
market value over a specified period of time, expressed as a percentage, of an initial investment in specified common stock, with dividends reinvested, all as determined utilizing such methodology as the Committee, or its delegatee, shall approve,
with the average TSR for the final 30 business days of the period considered the TSR at the end of the period and with Common Stock valued for the beginning of the period as of the last preceding business day. In the event that the Committee, or its
delegatee, determines that a separation of the Corporation’s gas and electric businesses has occurred during the Performance Period, then, beginning with such occurrence, measurement of the Corporation’s TSR shall be based upon two equity
components, weighed 50% each, consisting of (i) the Corporation’s post-separation equity, and (ii) the equity of the separated entity, or entities, or successor(s), using the initial, respective equity value at such occurrence as the
basis of measurement, all as determined by the Committee, or its delegatee, in its sole discretion. 
 (b) In the event that, prior to the date that the
determination of the achievement of the Performance Goal is made, the Grantee’s continuous employment by the Corporation, including Subsidiaries, terminates, the Performance Shares subject to this Award are thereupon forfeited, except that if
such employment terminates (i) at a time when Grantee is eligible for an immediately payable early or normal retirement benefit under the Duke Energy Retirement Cash Balance Plan or Cinergy Corp. Non-Union Employees’ Pension Plan, or under
another retirement plan of the Corporation or a Subsidiary which plan the Committee, or its delegatee, in its sole discretion, determines to be the functional equivalent of the Duke Energy Retirement Cash Balance Plan or the 

 Cinergy Corp. Non-Union Employees’ Pension Plan (“Functional Equivalent Plan”), unless the Committee, or
its delegatee, in its sole discretion, determines that Grantee is in violation of any obligation identified in Section 3, (ii) as the result of the Grantee’s death, (iii) as the result of the Grantee’s permanent and total
disability within the meaning of Code Section 22(e)(3), (iv) as the result of the termination of such employment by the Corporation, or employing Subsidiary, other than for cause, as determined by the Corporation or employing Subsidiary,
in its sole discretion, or (v) as the direct and sole result, as determined by the Corporation, or employing Subsidiary, in its sole discretion, of the divestiture of assets, a business, or a company, by the Corporation or a Subsidiary, the
Performance Shares subject to this Award shall vest upon such determination of the achievement of the Performance Goal, at such vesting percentage determined by the Committee, or its delegatee, in its sole discretion, by prorating on the basis of
the portion of the Performance Period that such employment continued while Grantee was entitled to payment of salary (unless such termination occurs after the end of the Performance Period, in which event the number of Performance Shares earned, if
any, shall not be prorated). 
 In the event that Grantee is on an employer-approved, personal leave of absence on the date that the determination of the
achievement of the Performance Goal is made, then, unless prohibited by law, vesting shall be postponed and shall not occur unless and until Grantee returns to active service in accordance with the terms of the approved personal leave of absence and
before the tenth anniversary of the Date of Grant. Further, in the event that such determination is made and during any portion of the Performance Period the Grantee was on employer-approved, personal leave of absence, the applicable vesting
percentage shall be determined by the Committee, or its delegatee, in its sole discretion, to reflect only that portion of the Performance Period during which such employment continued while the Grantee was entitled to payment of salary. 

(c) In the event that a Change in Control occurs before the Performance Period has ended and (i) before the Grantee’s continuous employment by the
Corporation, including Subsidiaries, terminates, or (ii) after such employment terminates during the Performance Period, (A) at a time when Grantee is eligible for an immediately payable, early or normal retirement benefit under the Duke
Energy Retirement Cash Balance Plan or Cinergy Corp. Non-Union Employees’ Pension Plan, or Functional Equivalent Plan, unless the Corporation, in its sole discretion, determines that Grantee is in violation of any obligation identified in
Section 3, or (B) as the result of an event listed in items (ii) – (v) of the first sentence of Section 2(b), the Performance Shares subject to this Award shall vest upon such occurrence, at such vesting percentage
determined by the Committee, or its delegatee, in its sole discretion, by prorating down, assuming a TSR at the          percentile (i.e., target performance), on the basis of the portion of the
Performance Period that has elapsed prior to the time of such occurrence (or such earlier termination of employment), and the remaining Performance Shares shall be forfeited, irrespective of any subsequent determination of the achievement of the
Performance Goal. 

 Section 3. Violation of Grantee Obligation. In consideration of the
continued vesting opportunity provided under Section 2 following the termination of Grantee’s continuous employment by the Corporation, including Subsidiaries, if, at any time of such termination of employment, Grantee is eligible for an
immediately payable early or normal retirement benefit under the Duke Energy Retirement Cash Balance Plan or Cinergy Corp. Non-Union Employees’ Pension Plan or Functional Equivalent Plan, Grantee agrees that during the period beginning with
such termination of employment and ending with the third anniversary of the Date of Grant (“Restricted Period”), Grantee shall not (i) without the prior written consent of the Corporation, or its delegatee, become employed by, serve
as a principal, partner, or member of the board of directors of, or in any similar capacity with, or otherwise provide service to, a competitor, to the detriment, of the Corporation or any Subsidiary, or (ii) violate any of Grantee’s other
noncompetition obligations, or any of Grantee’s nonsolicitation or nondisclosure obligations, to the Corporation or any Subsidiary. The noncompetition obligations of clause (i) of the preceding sentence shall be limited in scope and shall
be effective only to competition with the Corporation or any Subsidiary in the businesses of: production, transmission, distribution, or retail or wholesale marketing or selling of electricity; gathering, processing or transmission of natural gas,
resale or arranging for the purchase or for the resale, brokering, marketing, or trading of natural gas, electricity or derivatives thereof; energy management and the provision of energy solutions; gathering, compression, treating, processing,
fractionation, transportation, trading, marketing of natural gas components, including natural gas liquids; management of land holdings and development of commercial, residential and multi-family real estate projects; development and management of
fiber optic communications systems; development and operation of power generation facilities, and sales and marketing of electric power and natural gas, domestically and abroad; and any other business in which the Corporation, including
Subsidiaries, is engaged at the termination of Grantee’s continuous employment by the Corporation, including Subsidiaries; and within the following geographical areas (i) any country in the world where the Corporation, including
Subsidiaries, has at least US$25 million in capital deployed as of termination of Grantee’s continuous employment by Corporation, including Subsidiaries; (ii) the continent of North America; (iii) the United States of America and
Canada; (iv) the United States of America; (v) the states of North Carolina, South Carolina, Virginia, Georgia, Florida, Texas, California, Massachusetts, Illinois, Michigan, New York, Colorado, Oklahoma and Louisiana; (vi) the states
of North Carolina, South Carolina, Texas and Colorado; (vii) following consummation of the transactions contemplated by the Merger Agreement, the states of Ohio, Colorado, Kentucky, and Indiana; and (viii) any state or states with respect
to which was conducted a business of the Corporation, including Subsidiaries, which business constituted a substantial portion of Grantee’s employment. The Corporation and Grantee intend the above restrictions on competition in geographical
areas to be entirely severable and independent, and any invalidity or enforceability of this provision with respect to any one or more of such restrictions, including areas, shall not render this provision unenforceable as applied to any one or more
of the other restrictions, including areas. If any part of this provision is held to be unenforceable because of the duration, scope or area covered, the Corporation and Grantee agree to modify such part, or that the court making such holding shall
have the 

 power to modify such part, to reduce its duration, scope or area, including deletion of specific words and phrases, i.e.,
“blue penciling”, and in its modified, reduced or blue pencil form, such part shall become enforceable and shall be enforced. Nothing in Section 3 shall be construed to prohibit Grantee being retained during the Restricted Period in a
capacity as an attorney licensed to practice law, or to restrict Grantee providing advice and counsel in such capacity, in any jurisdiction where such prohibition or restriction is contrary to law. 
 Section 4. Forfeiture/Expiration. Any Performance Share subject to this Award shall be forfeited upon the
termination of the Grantee’s continuous employment by the Corporation, including Subsidiaries, from the Date of Grant, except to the extent otherwise provided in Section 2, and, if not previously vested and paid, or deferred, or forfeited,
shall expire immediately before the tenth (10th) anniversary of the Date of Grant. Any Dividend Equivalent
subject to this Award shall expire at the time its tandem Performance Share (i) is vested and paid, or deferred, (ii) is forfeited, or (iii) expires. 
 Section 5. Dividend Equivalent Payment. Payment with respect to any Dividend Equivalent subject to this Award that is in tandem with a Performance Share that is vested and paid
shall be paid in cash to the Grantee as soon as practicable following the vesting and payment of the Performance Share, or, if the vested Performance Share is deferred by Grantee as provided in Section 6, payment with respect to the tandem
Dividend Equivalent shall likewise be deferred. The Dividend Equivalent payment amount shall equal the aggregate cash dividends declared and paid with respect to one (1) share of Common Stock for the period beginning on the Date of the Award
and ending on the date the vested, tandem Performance Share is paid or deferred and before the Dividend Equivalent expires. However, should the timing of a particular payment under Section 6 to the Grantee in shares of Common Stock in
conjunction with the timing of a particular cash dividend declared and paid on Common Stock be such that the Grantee receives such shares without the right to receive such dividend and the Grantee would not otherwise be entitled to payment under the
expiring Dividend Equivalent with respect to such dividend, the Grantee, nevertheless, shall be entitled to such payment. Dividend Equivalent payments shall be subject to withholding for taxes. 
 Section 6. Payment of Performance Shares. Payment of Performance Shares subject to this Award shall be made to the
Grantee as soon as practicable following the time such Performance Shares become vested in accordance with Section 2 prior to their expiration but in no event later than 30 days following such vesting event, except to the extent deferred by the
Grantee in accordance with such procedure as the Committee, or its designee, may prescribe. Payment shall be subject to withholding for taxes. Payment shall be in the form of one (1) share of Common Stock for each full vested Performance Share,
and any fractional vested Performance Share shall be rounded up to the next whole share for purposes of both vesting under Section 2 and payment under Section 6. Notwithstanding the foregoing, to the extent Grantee fails to timely tender
to the Corporation sufficient cash to satisfy withholding for tax requirements, such unsatisfied withholding shall be applied to reduce the number of 

 shares of Common Stock that would otherwise be paid (valued at Fair Market Value on the date the respective Performance
Shares became vested). In the event that payment, after any such reduction in the number of shares of Common Stock to satisfy withholding for tax requirements, would be for less than ten (10) shares of Common Stock, then, if so determined by
the Committee, or its delegatee, in its sole discretion, payment, instead of being made in shares of Common Stock, shall be made in a cash amount equal in value to the shares of Common Stock that would otherwise be paid, valued at Fair Market Value
on the date the respective Performance Shares became vested. 
 Section 7. No Employment Right. Nothing in
this Agreement or in the Plan shall confer upon the Grantee the right to continued employment with the Corporation or any Subsidiary, or affect the right of the Corporation or any Subsidiary to terminate the employment or service of the Grantee at
any time for any reason. 
 Section 8. Nonalienation. The Performance Shares and Dividend Equivalents
subject to this Award are not assignable or transferable by Grantee. Upon any attempt to transfer, assign, pledge, hypothecate, sell or otherwise dispose of any such Performance Share or Dividend Equivalent, or of any right or privilege conferred
hereby, or upon the levy of any attachment or similar process upon such Performance Share or Dividend Equivalent, or upon such right or privilege, such Performance Share or Dividend Equivalent, or such right or privilege, shall immediately become
null and void. 
 Section 9. Determinations. Determinations by the Committee, or its delegatee, shall
be final and conclusive with respect to the interpretation of the Plan and this Agreement. 
 Section 10. Governing
Law. This Agreement shall be governed, construed and enforced in accordance with the laws of the State of Delaware applicable to transactions that take place entirely within that state. 
 Section 11. Certain Definitions. The following shall apply notwithstanding anything in this Agreement or the Plan
to the contrary. The term “Change in Control” has the meaning given such term in Section 12.2 of the Duke Energy Corporation 1998 Long-Term Incentive Plan, as amended; provided, however, that no Change in Control shall
be deemed to occur in respect of any transactions or events resulting from the separation of the Corporation’s gas and electric businesses. The term “Merger Agreement” shall mean the Agreement and Plan of Merger dated as of
May 8, 2005 by and among the Duke Energy Corporation, Cinergy Corp., Deer Holding Corp., Deer Acquisition Corp. and Cougar Acquisition Corp., as it may be amended. The term “Subsidiaries” shall mean any entity that is wholly owned,
directly or indirectly, by the Corporation, or any other affiliate of the Corporation that is so designated, from time to time, by the Committee. For purposes of this Agreement, the Grantee shall be considered to be eligible for an early retirement
benefit under the Cinergy Corp. Non-Union Employees’ Pension Plan only if the Grantee has attained age 55 and satisfied all other applicable requirements of such plan. 

 Section 12. Conflicts with Plan, Correction of Errors, and Grantee’s
Consent. In the event that any provision of this Agreement conflicts in any way with a provision of the Plan, such Plan provision shall be controlling and the applicable provision of this Agreement shall be without force and effect to the
extent necessary to cause such Plan provision to be controlling. In the event that, due to administrative error, this Agreement does not accurately reflect an Award properly granted to the Grantee pursuant to the Plan, the Corporation, acting
through its Executive Compensation and Benefits Department, reserves the right to cancel any erroneous document and, if appropriate, to replace the cancelled document with a corrected document. It is the intention of the Corporation and the Grantee
that this Award not result in unfavorable tax consequences to Grantee under Code Section 409A. Accordingly, Grantee consents to such amendment of this Agreement as the Corporation may reasonably make in furtherance of such intention, and the
Corporation shall promptly provide, or make available to, Grantee a copy of any such amendment. 
 Notwithstanding the foregoing, this Award
is subject to cancellation by the Corporation in its sole discretion unless the Grantee, by not later than                 
        , has signed a duplicate of this Agreement, in the space provided below, and returned the signed duplicate to the Executive Compensation and Benefits Department - Performance Award
[(ST05F)], Duke Energy Corporation, P. O. Box 1007, Charlotte, NC 28201-1007, which, if, and to the extent, permitted by the Executive Compensation and Benefits Department, may be accomplished by electronic means. 

 IN WITNESS WHEREOF, the Corporation has caused this Agreement to be executed and granted in Charlotte,
North Carolina, to be effective as of the Date of Grant. 
  

							
	ATTEST	 	DUKE ENERGY CORPORATION
				
	By:	 	  
	 	By:	 	  

		 	Corporate Secretary	 	Its:	 	Chief Executive Officer

 Acceptance of Performance Award 
 IN WITNESS OF Grantee’s acceptance of this Performance Award and Grantee’s agreement to be bound by the provisions of this Agreement and the
Plan, Grantee has signed this Agreement this          day of
                            . 
  

	
	  

	Grantee’s Signature
	
	  

	(print name)
	
	  

	(social security number)
	
	  

	(address)Form of Warrant to Purchase Common Stock

 Exhibit 4.1 
 THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT
PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED. 
 Issue Date: [DATE] 
 AKESIS PHARMACEUTICALS, INC. 
 WARRANT TO PURCHASE COMMON STOCK 
 This Warrant to Purchase Common Stock (the “Warrant”) is issued to [NAME] (the “Holder”) by Akesis Pharmaceuticals, Inc., a Nevada corporation (the “Company”), pursuant
to the terms of that certain Common Stock and Warrant Purchase Agreement (the “Purchase Agreement”) dated as of [DATE] between the Company and certain purchasers of the Company’s Common Stock. 
 1. Purchase of Shares. Subject to the terms and conditions hereinafter set forth and set forth in the Purchase Agreement, the Holder of this
Warrant is entitled during the Exercise Period, upon surrender of this Warrant at the principal office of the Company (or at such other place as the Company shall notify the Holder hereof in writing), to purchase, in whole or in part, from the
Company [ ### ] fully paid and nonassessable Shares, at an exercise price per share equal to the Exercise Price (as defined below). 
 2. Definitions. 
 (a) “Act” shall mean the Securities Act of 1933, as amended.

 (b) “Exercise Price” shall mean $3.00. 
 (c) “Exercise Period” shall mean the term commencing on the date of issuance of this Warrant and ending on the
expiration of this Warrant pursuant to Section 14 hereof. 
 (d) “Shares” shall mean shares of
the Company’s Common Stock. 
 (e) “Change of Control” shall mean (i) a sale, lease or
disposition of all or substantially all of the assets of the Company, or (ii) a merger or consolidation (in a single transaction or a series of related transactions) of the Company with or into any other corporation or corporations or other
entity, or any other corporate reorganization, where the stockholders of the Company immediately prior to such event do not retain more than fifty percent (50%) of the voting power of and interest in the successor entity (excluding any
transactions if the primary purpose of the transaction is to obtain financing from new or existing investors). 

 3. Method of Exercise. While this Warrant remains outstanding and exercisable in accordance with
Section 1 above, the Holder may exercise, in whole or in part, the purchase rights evidenced hereby. Such exercise shall be effected by: 
 (a) the surrender of the Warrant, together with a notice of exercise to the Secretary of the Company at its principal offices; and 
 (b) the payment to the Company of an amount equal to the aggregate Exercise Price for the number of Shares being purchased. 

4. Net Exercise. In lieu of cash exercising this Warrant, the Holder of this Warrant may elect to receive shares equal to the value of this
Warrant (or the portion thereof being canceled) by surrender of this Warrant at the principal office of the Company together with notice of such election, in which event the Company shall issue to the Holder hereof a number of Shares computed using
the following formula: 
  

									
		 		 	 X =
	  	 Y (A - B)
	  	
		 		 	  	      A      	  	

 Where 
  

	 	X —	    The number of Shares to be issued to the Holder of this Warrant. 

  

	 	Y —	    The number of Shares purchasable under this Warrant. 

  

	 	A —	    The fair market value of one Share. 

  

	 	B —	    The Exercise Price (as adjusted to the date of such calculations). 

 For purposes of this Section 4, the fair market value of a Share shall mean the average of the closing bid and asked prices of Shares quoted in the
over-the-counter market in which the Shares are traded or the closing price quoted on any exchange on which the Shares are listed, whichever is applicable, as published in the Western Edition of The Wall Street Journal for the ten
(10) trading days prior to the date of determination of fair market value (or such shorter period of time during which such stock was traded over-the-counter or on such exchange). If the Shares are not traded on the over-the-counter market or
on an exchange, the fair market value shall be the price per Share that the Company could obtain from a willing buyer for Shares sold by the Company from authorized but unissued Shares, as such prices shall be determined in good faith by the
Company’s Board of Directors. 
 5. Certificates for Shares. Upon the exercise of the purchase rights evidenced by this Warrant,
one or more certificates for the number of Shares so purchased shall be issued as soon as practicable thereafter, and in any event within thirty (30) days of the delivery of the subscription notice. 
 6. Issuance of Shares. The Company covenants that the Shares, when issued pursuant to the exercise of this Warrant, will be duly and validly
issued, fully paid and nonassessable and free from all taxes, liens, and charges with respect to the issuance thereof. 
  

 -2- 

 7. Adjustment of Exercise Price and Number of Shares. The number of and kind of securities
purchasable upon exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time as follows: 
 (a) Subdivisions, Combinations and Other Issuances. If the Company shall at any time prior to the expiration of this Warrant subdivide the Shares, by split-up or otherwise, or combine its Shares, or issue additional shares of its
Shares as a dividend, the number of Shares issuable on the exercise of this Warrant shall forthwith be proportionately increased in the case of a subdivision or stock dividend, or proportionately decreased in the case of a combination. Appropriate
adjustments shall also be made to the purchase price payable per share, but the aggregate purchase price payable for the total number of Shares purchasable under this Warrant (as adjusted) shall remain the same. Any adjustment under this
Section 7(a) shall become effective at the close of business on the date the subdivision or combination becomes effective, or as of the record date of such dividend, or in the event that no record date is fixed, upon the making of such
dividend. 
 (b) Reclassification, Reorganization and Consolidation. In case of any reclassification, capital
reorganization, or change in the capital stock of the Company (other than as a result of a subdivision, combination, or stock dividend provided for in Section 7(a) above), then the Company shall make appropriate provision so that the Holder of
this Warrant shall have the right at any time prior to the expiration of this Warrant to purchase, at a total price equal to that payable upon the exercise of this Warrant, the kind and amount of shares of stock and other securities and property
receivable in connection with such reclassification, reorganization, or change by a Holder of the same number of Shares as were purchasable by the Holder of this Warrant immediately prior to such reclassification, reorganization, or change. In any
such case appropriate provisions shall be made with respect to the rights and interest of the Holder of this Warrant so that the provisions hereof shall thereafter be applicable with respect to any shares of stock or other securities and property
deliverable upon exercise hereof, and appropriate adjustments shall be made to the purchase price per share payable hereunder, provided the aggregate purchase price shall remain the same. 
 (c) Notice of Adjustment. When any adjustment is required to be made in the number or kind of shares purchasable upon exercise of
the Warrant, or in the Exercise Price, the Company shall promptly notify the Holder of such event and of the number of Shares or other securities or property thereafter purchasable upon exercise of this Warrant. 
 8. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant,
but in lieu of such fractional shares the Company shall make a cash payment therefor on the basis of the Exercise Price then in effect. 
 9.
Representations of the Company and the Holder. The Company represents that all corporate actions on the part of the Company, its officers, directors and stockholders necessary for the sale and issuance of this Warrant have been taken. The
Holder represents and acknowledges that the Warrant may be transferred in accordance with transfer restrictions set forth in the Purchase Agreement. 
  

 -3- 

 10. Restrictive Legend. The Shares (unless registered under the Act) shall be stamped or imprinted
with a legend in substantially the following form (in addition to any other applicable legends as set forth in the Purchase Agreement): 
 THE
SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF, AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. SUCH SHARES MAY
NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. COPIES OF THE AGREEMENT COVERING THE PURCHASE OF THESE SHARES AND RESTRICTING THEIR TRANSFER MAY BE
OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE COMPANY AT THE PRINCIPAL EXECUTIVE OFFICES OF THE COMPANY. 
 11. Rights of Stockholders. No holder of this Warrant shall be entitled, as a Warrant holder, to vote or receive dividends or be deemed the holder of the Shares or any other securities of the Company which may
at any time be issuable on the exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the Holder of this Warrant, as such, any of the rights of a stockholder of the Company or any right to vote for the
election of directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action (whether upon any recapitalization, issuance of stock, reclassification of stock, change of par value,
consolidation, merger, conveyance, or otherwise) or to receive notice of meetings, or to receive dividends or subscription rights or otherwise until the Warrant shall have been exercised and the Shares purchasable upon the exercise hereof shall have
become deliverable, as provided herein. 
 12. Expiration of Warrant; Notice of Certain Events Terminating This Warrant. 

(a) This Warrant shall expire and shall no longer be exercisable upon the earliest to occur of: 
 (i) 5:00 p.m., California local time, on the date of the third anniversary of the Initial Closing (as defined in the Purchase
Agreement); or 
 (ii) Any Change of Control. 
 (b) The Company shall provide at least ten (10) days prior written notice of any event set forth in Section 12(a)(ii).

 13. Notices. All notices and other communications required or permitted hereunder shall be in writing, shall be effective when
given, and shall in any event be deemed to be given upon receipt or, if earlier, (a) five (5) days after deposit with the U.S. Postal Service or other applicable postal service, if delivered by first class mail, postage prepaid,
(b) upon delivery, if delivered by hand, (c) one business day after the business day of deposit with Federal Express or 

  

 -4- 

 
similar overnight courier, freight prepaid or (d) one business day after the business day of facsimile transmission, if delivered by facsimile
transmission with copy by first class mail, postage prepaid, and shall be addressed (i) if to the Holder, at the Holder’s address as set forth on the Schedule of Investors to the Purchase Agreement, and (ii) if to the Company, at the
address of its principal corporate offices (attention: President), or at such other address as a party may designate by ten days advance written notice to the other party pursuant to the provisions above. 
 14. Governing Law. This Warrant and all actions arising out of or in connection with this Agreement shall be governed by and construed in
accordance with the laws of the State of California, without regard to the conflicts of law provisions of the State of California or of any other state. 
 15. Rights and Obligations Survive Exercise of Warrant. Unless otherwise provided herein, the rights and obligations of the Company, of the Holder of this Warrant and of the holder of the Shares issued upon
exercise of this Warrant, shall survive the exercise of this Warrant. 
 [Remainder of page intentionally left blank.] 
  

 -5- 

 This Warrant to Purchase Common Stock is issued as of the date first set forth above. 
  

			
	AKESIS PHARMACEUTICALS, INC.
		
	 By:
	 	  
		 	 Edward B. Wilson, Chief Executive Officer

 AKESIS PHARMACEUTICALS, INC. 
 SIGNATURE PAGE TOWARRANT TO PURCHASE COMMON
STOCK 

 EXHIBIT A 
 NOTICE OF EXERCISE 
  

	TO:	Akesis Pharmaceuticals, Inc. 

 Attention: President

 1. The undersigned hereby elects to purchase
                     Shares of Common Stock of Akesis Pharmaceuticals, Inc. pursuant to the terms of the attached Warrant. 
 2. Method of Exercise (Please initial the applicable blank): 
  

	 	 ̈	The undersigned elects to exercise the attached Warrant by means of a cash payment, and tenders herewith payment in full for the purchase price of the shares being purchased,
together with all applicable transfer taxes, if any. 

  

	 	 ̈	The undersigned elects to exercise the attached Warrant by means of the net exercise provisions of Section 4 of the Warrant. 

 3. Please issue a certificate or certificates representing said Shares in the name of the undersigned or in such other name as is specified below:

  

					
		  	  	  	
		  	(Name)	  	
			
		  	  	  	
			
		  	  	  	
		  	(Address)	  	

 4. The undersigned hereby represents and warrants that the aforesaid Shares are being acquired for
the account of the undersigned for investment and not with a view to, or for resale, in connection with the distribution thereof, and that the undersigned has no present intention of distributing or reselling such shares and all representations and
warranties of the undersigned set forth in Section 4 of the Purchase Agreement (as defined in the Warrant) are true and correct as of the date hereof. 
  

					
			
	 	 		 	   
		 		 	(Signature)
			
	 	 		 	   
		 		 	(Name)
			
	   	 		 	   
	(Date)	 		 	(Title)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}]]